Chemours chooses Wilmington, Delaware for its global HQ

Chemours has announced that it will locate its global headquarters in Wilmington, Delaware, USA.

”While we like to think of ourselves as a 200-year-old start-up, we’ve been an independent, publicly traded company for only just more than a year now,” said President and CEO Mark Vergnano. "We’ve accomplished a good deal in a short time, standing up Chemours and making a host of decisions that ensure a sound and prosperous future. We have considered a number of locations for our world headquarters but, in the end, it came down to what locale makes the most financial sense, offers our current workforce the right combination of amenities and conveniences and allows us to attract great talent. Wilmington is that place and we look forward to being part of its future growth.”

Chemours began evaluating headquarters location options more than six months ago with Delaware, New Jersey, and Pennsylvania all under active consideration. The company followed a disciplined evaluation process against a range of criteria, including quality of life for employees, access to a strong talent pool and a positive, long-term financial case for the company.

"Chemours has a first-rate workforce and the state of Delaware has a rich talent pool so we believe Delaware’s a great place for maintaining our superb employee base. That’s a competitive advantage for us,” Vergnano added.

Recent changes to the state’s corporate tax structure brought about by the Delaware Competes Act, which was approved earlier this year with overwhelming, bi-partisan support of the Delaware legislature, were key components in Chemours’ decision.

"Today’s announcement is the result of strong support from Delaware’s elected officials at the federal, state and local levels, notably Governor Jack Markell, who spearheaded passage of the Delaware Competes Act along with Senate President Pro-Tem Patricia Blevins and House Majority Leader Valerie Longhurst. Solid relationships with Wilmington Mayor Dennis Williams, United States Senators Tom Carper and Chris Coons, as well as Congressman John Carney also helped drive our decision. Chemours has enjoyed substantive dialogue with these leaders about issues of importance to our company, employees and future,” said Vergnano.